Close Menu

Sr Manager, Algorithm Development

Organization
Thermo Fisher Scientific
Job Location
200 Oyster Point Blvd
South San Francisco, CA 94080
United States
Job Description

How will you make an impact?

You will be a part of the fast-growing field of Clinical Diagnostics developing algorithms for molecular diagnostics based on real-time PCR technologies. Your interaction and collaboration with a talented team of assay, reagents, software, hardware designers and manufacturing will revolutionize healthcare through high throughput diagnostic systems. Thermo Fisher Scientific Inc. has played a pivotal role in the COVID-19 pandemic with the TaqPath COVID-19 Combo Kit for testing SARS-CoV-2. We continue to innovate and provide new solutions for the pandemic and we need your talent to help save lives.

 

What will you do?

  • Manage a team of algorithm developers by developing and expanding team skills
  • Provide leadership in career development
  • Project management by aligning skills with tasks, scheduling and prioritization
  • Clearly defining algorithm development goals and success criteria
  • Spearhead the acquisition and generation of data to support development and testing
  • Develop collaborations with academic and commercial labs
  • Develop standards and process for operations
  • Work closely with team to accomplish goals and review progress
  • Manage upwards by aligning management goals and expectations

 

What will your team do?

  • Develop algorithms to classify results of qPCR molecular tests
  • Develop algorithms for detection of workflow failures, sample collection failures and qPCR issues
  • Develop software and analysis pipelines for data mining large datasets
  • Develop classification algorithms and model data
  • Perform root cause analysis
  • Review and analyze customer data and results
  • Collaborate and communicate with various teams and business units

 

How will you get here?

Bachelor's in Molecular Biology, Biology, Chemistry, Applied Mathematics, Physics, Electrical Engineering, Computational Biology, Biostatistics, Bioinformatics, Computer Science or related discipline; postgraduate degree (Masters, PhD) is highly preferred

 

  • 2+ years of experience in leading algorithm/software development teams in clinical diagnostics
  • 5+ years of experience as an algorithm developer
  • 3+ years of product development experience (biotechnology industry preferred)
  • Strong hands on data analytics, statistical modeling, and classifiers experience
  • Data structures and common methods in data transformation
  • Pattern recognition, predictive modeling skills, machine learning, deep learning
  • Excellent programming skills in C++, Java or Python
  • Experience utilizing Matlab

 

Knowledge, Skills, Abilities

  • Understanding of clinical trial design and evaluation
  • Knowledge in Molecular Biology, Clinical Diagnostics
  • Strong understanding of qPCR and amplification curve data
  • Prior experience with US-FDA 510k product development/submission, 21 CFR Part 11, and ISO 13485 is highly preferred
  • Ability to present and communicate data analysis results to non-experts
  • Ability to work independently and in a team environment
About Our Organization

You will be a part of the fast-growing field of Clinical Diagnostics developing algorithms for molecular diagnostics based on real-time PCR technologies. Your interaction and collaboration with a talented team of assay, reagents, software, hardware designers and manufacturing will revolutionize healthcare through high throughput diagnostic systems. Thermo Fisher Scientific Inc. has played a pivotal role in the COVID-19 pandemic with the TaqPath COVID-19 Combo Kit for testing SARS-CoV-2. We continue to innovate and provide new solutions for the pandemic and we need your talent to help save lives.

A new report finds that women, especially women of color, are missing among the high-earners at research universities in the US, the Chronicle of Higher Education writes. 

Researcher-parents, especially mothers of small children, have lost research time during the COVID-19 pandemic, according to the Chronicle of Higher Education.

Inside Higher Ed reports that the preprint site medRxiv has taken off with the COVID-19 pandemic.

Inside Higher Ed reports some university professors are pushing back against plans for increased numbers of in-person classes for next semester.